Occam Places Amgen CMO on Board of Moonwalk
In June 2025, Occam Global placed Paul Burton, MD, PhD, on the Board of Moonwalk Biosciences.
Burton became Amgen’s CMO in June 2023. Prior to joining Amgen, he served as the CMO of Moderna Therapeutics from 2021 to 2023 and spent 16 years at J&J, where his most recent role was Chief Global Medical Affairs Officer.
Burton has over 20 years of experience in the biopharmaceutical industry, covering all phases of drug discovery and development, including both small and large molecules, as well as mRNA therapeutics. He has also worked in various therapeutic areas, such as oncology, cardiovascular and metabolic diseases, and infectious diseases.
He earned his BSc in Physiology from King’s College London, his MD from the University of London, and his PhD in Philosophy from Imperial College London.
Read more about Occam's biotech board recruiting:
Bob D. Brown for Mammoth Biosiences
Namandje Bumpus, PhD and Elaine Sun for Recursion
Stephen M. Hahn, MD for Faeth Therapeutics
Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.